Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition. - Wikidata - wikimedia - TriplyDB

Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.

Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.

http://www.wikidata.org/entity/Q35356072

about

Salinomycin Abolished STAT3 and STAT1 Interactions and Reduced Telomerase Activity in Colorectal Cancer Cells.Long noncoding RNA lncTCF7, induced by IL-6/STAT3 transactivation, promotes hepatocellular carcinoma aggressiveness through epithelial-mesenchymal transition Ginkgo biloba extract mitigates liver fibrosis and apoptosis by regulating p38 MAPK, NF-κB/IκBα, and Bcl-2/Bax signaling Interleukin 6 trigged ataxia-telangiectasia mutated activation facilitates lung cancer metastasis via MMP-3/MMP-13 up-regulation Upregulation of H19 indicates a poor prognosis in gallbladder carcinoma and promotes epithelial-mesenchymal transition.Prognostic Impact of IL6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based Chemotherapy.Serglycin as a potential biomarker for glioma: association of serglycin expression, extent of mast cell recruitment and glioblastoma progression.Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line.Recombinant soluble gp130 protein reduces DEN-induced primary hepatocellular carcinoma in mice.Interplay Between Transcription Factors and MicroRNAs Regulating Epithelial-Mesenchymal Transitions in Colorectal Cancer.Anticancer effect of cucurbitacin B on MKN-45 cells via inhibition of the JAK2/STAT3 signaling pathway.Recent progress on the effects of microRNAs and natural products on tumor epithelial-mesenchymal transition.ZEB1-regulated inflammatory phenotype in breast cancer cells.MLK3 regulates FRA-1 and MMPs to drive invasion and transendothelial migration in triple-negative breast cancer cells.ING5 knockdown enhances migration and invasion of lung cancer cells by inducing EMT via EGFR/PI3K/Akt and IL-6/STAT3 signaling pathways.miR-497 suppresses epithelial-mesenchymal transition and metastasis in colorectal cancer cells by targeting fos-related antigen-1.Activation of adrenergic receptor β2 promotes tumor progression and epithelial mesenchymal transition in tongue squamous cell carcinoma.Irisin reverses the IL-6 induced epithelial-mesenchymal transition in osteosarcoma cell migration and invasion through the STAT3/Snail signaling pathway.Interleukin-6/signal transducer and activator of transcription 3 promotes prostate cancer resistance to androgen deprivation therapy via regulating pituitary tumor transforming gene 1 expression.CXCR2+ MDSCs promote breast cancer progression by inducing EMT and activated T cell exhaustion.Enhancer transcription reveals subtype-specific gene expression programs controlling breast cancer pathogenesis.IL-37 inhibits invasion and metastasis in non-small cell lung cancer by suppressing the IL-6/STAT3 signaling pathway.The expression analysis of Fra-1 gene and IL-11 protein in Iranian patients with ulcerative colitis.Effects and mechanism of STAT3 silencing on the growth and apoptosis of colorectal cancer cells

P2860

Q33658135-A7C7ECF2-03B8-4FCF-AF04-02AA5B35F711 Q36144048-A4BCD1E7-1133-4EE1-A345-C7A04D3E9BAD Q36352193-EDA92EBD-6602-415A-BBC9-14CDA7B7DA5E Q36562147-1821FDCB-E6B3-4F5E-B924-A795732274BC Q36595032-B0DFB914-5E4D-4728-81B9-21B83EE588CD Q37059793-A7E5FA96-8C69-403A-802D-420FA86DBAB4 Q38690536-3DBC1F25-B037-4C3D-8B99-557DCCE27A30 Q38704813-99595B00-266D-4F03-8CF6-9E1E640E2F10 Q38778160-3624D81E-FC1B-4A98-A5B2-98BE50CFDF02 Q38940594-E1F6EF24-BFD4-414A-BF92-1BE15051B330 Q39326252-EB83E042-D983-43F7-AE54-8286DFC016D6 Q39458257-265A67B9-828F-421F-A62A-433363A2A0BB Q40171088-1680FAA0-D3E5-4D60-8738-81804347AF18 Q41072269-70869CE7-3446-448E-A752-218A54C8971F Q41552636-399FEA0A-BA28-4A49-AC40-C6F78EFB0DA1 Q41628161-234926ED-93B6-4F1C-8746-C747CFFF2E27 Q47104680-117548C1-CCD2-4DCD-AF36-4E4A351A157B Q49475451-9F2A7CEF-FEF6-4E7A-87B4-D2E0F3CEC708 Q49483643-40BB4F00-F45D-4EE0-88DD-A90F72FAB500 Q49569708-91D73AED-B66D-4B4F-AFE9-1EBA26536605 Q49607235-F4EFD5D9-4094-4A06-9888-B41836D0AE84 Q52633205-84FF9C1D-394D-473E-AFC5-B41CFCD1259B Q55317363-C6B65DB9-6742-4038-83A0-806DFB73D6E8 Q57788839-C6B97BA9-1EB7-4F3E-AC9B-D5538D5669F5

P2860

Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.

http://www.wikidata.org/entity/Q35356072

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Aberrantly expressed Fra-1 by ...... helial-mesenchymal transition.

@ast

Aberrantly expressed Fra-1 by ...... helial-mesenchymal transition.

@en

type

label

Aberrantly expressed Fra-1 by ...... helial-mesenchymal transition.

@ast

Aberrantly expressed Fra-1 by ...... helial-mesenchymal transition.

@en

prefLabel

Aberrantly expressed Fra-1 by ...... helial-mesenchymal transition.

@ast

Aberrantly expressed Fra-1 by ...... helial-mesenchymal transition.

@en

P1433

Q35356072-C8B83908-F66B-498A-B947-373C0250DD3C

P1476

Q35356072-9A0586A3-F5A7-41BF-84B8-13DB642B7040

P2093

Q35356072-0C345C9B-310C-4796-9F6A-F020F732D2FB

Q35356072-158A7108-83FE-4692-BDB0-185BE18C8616

Q35356072-397C47A5-5128-4556-9A25-92A4521D95C7

Q35356072-8956AEC2-DBB3-4266-89A7-6DDD408197F0

Q35356072-9540BF3A-62EF-4107-B408-464049EC5BDF

Q35356072-A3865009-785E-43E1-9B58-D0647AC5B0D6

Q35356072-ABFBE461-9843-4020-8AB0-E3F534935960

Q35356072-BF065F43-9E0B-414E-8C1D-E3CC1BE01321

Q35356072-C3D32D4F-E53F-4791-9380-580B73624CB6

Q35356072-CC5B3F81-5F99-4D7B-ADD6-966A23D6848C

P2860

Q35356072-0199BDAF-2E06-439E-934C-7EB33E094150

Q35356072-024D2379-8039-4D28-ADA8-F86612F37F16

Q35356072-0CF7EC82-9318-4A53-9DCC-236C9A0D1D5A

Q35356072-1F2BD53A-386D-496F-B872-9D3B81EE6953

Q35356072-20B572EB-30B1-472C-B76A-8FBF4B5D5B2E

Q35356072-2222F981-818B-498E-A7B1-9FBCAAB4B832

Q35356072-23A301FD-60D1-46CE-B335-1EC524A8F5D5

Q35356072-23E8FBCC-73C8-4CC8-A095-91E5B82D7FD0

Q35356072-24DE80F4-EDF4-4C41-BC94-42FF9C29C072

Q35356072-260EB208-C519-4739-A37C-5765CD62742A

P304

Q35356072-7C36A455-1683-48D5-A5DB-0D2E7EB65949

P31

Q35356072-E83B9987-CF6C-4CB6-BCA5-67979D5DF73A

P356

Q35356072-D2B00510-C18E-45EE-A9B4-0E269BF221F9

P407

Q35356072-B6BBFF6E-2542-4B57-AA5E-8741AB9AD944

P433

Q35356072-CDEDFEAE-6260-4D41-9ACF-B1E09F605C1D

P478

Q35356072-C58A96FA-FC6C-4FBB-91BB-4144499CF66F

P577

Q35356072-C56B55AD-DE8B-4F58-ABE2-F3A49B343F42

P5875

Q35356072-7069EC73-4A3D-48BB-BF0C-EAA9CBDA7C7A

P698

Q35356072-C80ED7A5-E74F-4E6C-8FFA-48A7FC98EFE3

P921

Q35356072-85C41C87-1D9B-4F4D-96FE-4EAE4E26E835

P932

Q35356072-4C6E7B7F-2F7D-4917-8429-34D96ADEC048

P356

P1433

P1476

Aberrantly expressed Fra-1 by ...... helial-mesenchymal transition.

@en

P2093

Bo Wang

http://www.w3.org/2001/XMLSchema#string

Chaoju Gong

http://www.w3.org/2001/XMLSchema#string

Cheng Qian

http://www.w3.org/2001/XMLSchema#string

Guoping Ren

http://www.w3.org/2001/XMLSchema#string

Hong Liu

http://www.w3.org/2001/XMLSchema#string

Hongyan Qi

http://www.w3.org/2001/XMLSchema#string

Jimin Shao

http://www.w3.org/2001/XMLSchema#string

Jing Shen

http://www.w3.org/2001/XMLSchema#string

Lijun Zhu

http://www.w3.org/2001/XMLSchema#string

Maode Lai

http://www.w3.org/2001/XMLSchema#string

P2860

Interferon regulatory factor 1 transactivates expression of human DNA polymerase η in response to carcinogen N-methyl-N'-nitro-N-nitrosoguanidine

Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells

TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancer

Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis

Novel interactions between NFATc1 (Nuclear Factor of Activated T cells c1) and STAT-3 (Signal Transducer and Activator of Transcription-3) mediate G protein-coupled receptor agonist, thrombin-induced biphasic expression of cyclin D1, with first phas

Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer

EMT and dissemination precede pancreatic tumor formation

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

The effects and mechanisms of blockage of STAT3 signaling pathway on IL-6 inducing EMT in human pancreatic cancer cells in vitro.

P304

459-468

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CARCIN/BGV017

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273324088

http://www.w3.org/2001/XMLSchema#string

P698

25750173

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

4392608

http://www.w3.org/2001/XMLSchema#string